Since CKD after LT is caused mainly by CNIs7, tapering or withdrawal of CNIs and initiation of treatment with a mammalian target of rapamycin (m-TOR) inhibitor may potentially improve or slow the decline of renal function after LT23,24. The gene discussed is MTOR; the disease is chronic kidney disease.